Assessment of Real-Time Natural Language Processing for Improving Diagnostic Specificity: A Prospective, Crossover Exploratory Study.

Background:  Reliable, precise, timely, and clear documentation of diagnoses is difficult. Poor specificity or the absence of diagnostic documentation can lead to decreased revenue and increased payor denials, audits, and queries to providers. Nuance's Dragon Medical Advisor (DMA) is a computer-assisted physician documentation (CAPD) product.

Readmission Risk after COVID-19 Hospitalization: A Moderation Analysis by Vital Signs.

Objective: Readmission to the hospital after hospitalization with coronavirus disease 2019 (COVID-19) is associated with significant morbidity and mortality. Hospital clinicians may identify the presence of a patient's comorbid conditions, overall severity of illness, and clinical status at discharge as risk factors for readmission. Objective data are lacking to support reliance on these factors for discharge decision making.

Disease Severity in Vaccinated Adults Hospitalized with Breakthrough COVID-19.

Vaccination against SARS-CoV-2 is widely used and confers protection against morbidity and mortality in COVID-19. Little is known about disease severity and outcomes in fully vaccinated patients during hospitalization for COVID-19. To determine whether vaccination status and time from vaccination-to-hospitalization impacted disease severity in patients admitted with COVID-19.

Misguided Artificial Intelligence: How Racial Bias is Built Into Clinical Models.

Artificial Intelligence is being used today to solve a myriad of problems. While there is significant promise that AI can help us address many healthcare issues, there is also concern that health inequities can be exacerbated. This article looks specifically at predictive models in regards to racial bias.

Efficacy of remdesivir for hospitalized COVID-19 patients with end stage renal disease.

Background: Since the beginning of corona virus disease 2019 (COVID-19) pandemic, there has been a widespread use of remdesivir in adults and children. There is little known information about its outcomes in patients with end stage renal disease who are on dialysis.

Aim: To assess the clinical outcomes with use of remdesivir in adult patients with end stage kidney failure on hemodialysis.

Association of Treatment with Remdesivir and 30-day Hospital Readmissions in Patients Hospitalized with COVID-19.

Background: Since the beginning of COVID-19 pandemic, there has been a widespread use of remdesivir in adults and children. There is little known information about remdesivir's role in reducing 30-day readmissions after hospitalization with COVID-19. This study aimed to determine whether treatment with remdesivir was associated with reduced risk of 30-day readmission after index hospitalization with COVID-19.

Presentations and Outcomes of Severe Cardiac Complications in COVID-19: Rhode Island Experience.

Forty-one (41) patients admitted to Rhode Island hospitals with COVID-19 from April to November 2020 were identified to have severe cardiac complications. Clinical presentations of cardiovascular system toxicity in COVID-19 included myocarditis, pericarditis, cardiomyopathy, ACS and cardiac arrhythmia. Clinical features, hospital outcomes and post-discharge outcomes were characterized.